predigen 产品代理

产品分类 > 科研试剂 > predigen 产品代理

predigen 产品代理


我们的产品组合包括病毒、细菌和真菌感染、败血症、心血管疾病和辐射暴露的特征,并计划在自身免疫/炎症疾病和癌症方面开展工作。我们最先进的特征是针对传染病,特别是针对病毒和细菌感染的症状前检测,以及准确区分病毒和细菌感染的能力,以便能够适当地处方抗病毒药物和抗生素药物。
价格: 0.00

Coronavirus

 

Every infection, illness, or disease is an "insult" to human health and induces a natural response directly from our genes as the body tries to counter the insult and restore health. We call this reaction the “host response”. Immediately following exposure to an insult, the host response includes changes in gene expression, where specific genes are turned on or off and drive the overall response to address the insult. This gene expression produces messenger RNA (mRNA), which in turn are the building blocks for proteins that are sent to directly counteract the insult as the body attempts to restore health.

 

Our science is built on many years of experience, tens of thousands of patients enrolled globally, hundreds of thousands of biospecimens, and advanced machine learning. Over the past decade we have pioneered the use of host response as a means to diagnose and manage disease, and as a result we have developed robust host gene expression signatures that address unmet needs in medicine.

Our portfolio includes signatures for viral, bacterial and fungal infections, sepsis, cardiovascular disease, and radiation exposure with planned work in autoimmune/inflammatory disease and cancer.  Our most advanced signatures are for infectious disease, specifically the pre-symptomatic detection of viral and bacterial infections, and the ability to accurately discriminate viral from bacterial infections to enable appropriate prescription of antiviral an antibiotic medications.